[go: up one dir, main page]

DD202697A5 - Verfahren zur herstellung von alkansaeuren und deren derivate - Google Patents

Verfahren zur herstellung von alkansaeuren und deren derivate Download PDF

Info

Publication number
DD202697A5
DD202697A5 DD82240838A DD24083882A DD202697A5 DD 202697 A5 DD202697 A5 DD 202697A5 DD 82240838 A DD82240838 A DD 82240838A DD 24083882 A DD24083882 A DD 24083882A DD 202697 A5 DD202697 A5 DD 202697A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
compound
solution
acid
unsubstituted
Prior art date
Application number
DD82240838A
Other languages
German (de)
English (en)
Inventor
Stephen R Baker
William B Jamieson
William J Ross
Alec Todd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DD202697A5 publication Critical patent/DD202697A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B45/00—Formation or introduction of functional groups containing sulfur
    • C07B45/04—Formation or introduction of functional groups containing sulfur of sulfonyl or sulfinyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C07D303/42—Acyclic compounds having a chain of seven or more carbon atoms, e.g. epoxidised fats
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5304—Acyclic saturated phosphine oxides or thioxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5325—Aromatic phosphine oxides or thioxides (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD82240838A 1981-06-18 1982-06-17 Verfahren zur herstellung von alkansaeuren und deren derivate DD202697A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8118720 1981-06-18
GB8213211 1982-05-07

Publications (1)

Publication Number Publication Date
DD202697A5 true DD202697A5 (de) 1983-09-28

Family

ID=26279835

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82240838A DD202697A5 (de) 1981-06-18 1982-06-17 Verfahren zur herstellung von alkansaeuren und deren derivate

Country Status (23)

Country Link
US (1) US4513005A (sv)
EP (1) EP0068739B1 (sv)
KR (1) KR890000622B1 (sv)
AU (1) AU549814B2 (sv)
BG (1) BG37226A3 (sv)
CA (1) CA1224795A (sv)
CS (1) CS241109B2 (sv)
DD (1) DD202697A5 (sv)
DE (1) DE3261237D1 (sv)
DK (1) DK271682A (sv)
ES (3) ES513221A0 (sv)
FI (1) FI77847C (sv)
GB (1) GB2101594B (sv)
GR (1) GR76838B (sv)
HU (1) HU192105B (sv)
IE (1) IE53522B1 (sv)
IL (1) IL66056A0 (sv)
NZ (1) NZ200984A (sv)
PH (1) PH23051A (sv)
PL (4) PL137766B1 (sv)
PT (1) PT75058B (sv)
RO (1) RO83706B (sv)
ZA (1) ZA824294B (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4537723A (en) * 1982-02-04 1985-08-27 The Upjohn Company Derivatives of leukotrienes A and C
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
US4775662A (en) * 1983-03-07 1988-10-04 Smithkline Beckman Corporation Leukotriene antagonists
DE3469169D1 (en) * 1983-04-21 1988-03-10 Merck Frosst Canada Inc Leukotriene antagonists, their production and use and compositions containing them
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
US5017583A (en) * 1983-04-21 1991-05-21 Merck Frosst Canada, Inc. Leukotriene antagonists
US4720505A (en) * 1983-06-27 1988-01-19 Merck Frosst Canada, Inc. Leukotriene antagonists
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
AU572615B2 (en) 1983-12-27 1988-05-12 Sony Corporation Electrically conductive adhesive sheet circuit board and electrical connection structure
US4761425A (en) * 1983-12-27 1988-08-02 Merck Frosst Canada, Inc. Leukotriene antagonists
CA1288107C (en) * 1983-12-27 1991-08-27 Yves Girard Leukotriene antagonists
US4769386A (en) * 1984-06-18 1988-09-06 Smithkline Beckman Corporation Imidazolylthioalkenoic acids and -alkenols and leukotriene antagonistic composition containing them
IL75620A (en) * 1984-06-28 1989-05-15 Ciba Geigy Aliphatic thioethers of alkanoic acid derivatives,their manufacture and pharmaceutical compositions containing them
US4798842A (en) * 1984-07-18 1989-01-17 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4889873A (en) * 1984-07-18 1989-12-26 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4988716A (en) * 1984-07-18 1991-01-29 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4758594A (en) * 1984-07-18 1988-07-19 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds
US4874792A (en) * 1985-04-19 1989-10-17 Smithkline Beckman Corporation Thiophenyl Alkanoic acids useful as leukotriene antagonists
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
DE3672130D1 (de) * 1985-04-19 1990-07-26 Smithkline Beecham Corp Leukotrien-antagonisten.
US4937253A (en) * 1985-04-19 1990-06-26 Smithkline Beecham Corporation Ester prodrugs
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
US4990526A (en) * 1985-06-18 1991-02-05 Merck Frosst Canada, Inc. Leukotriene antagonists, compositions and methods of use thereof
US4696946A (en) * 1985-08-30 1987-09-29 Schering Corporation Topical Treatment of hyperproliferative skin diseases
US4783483A (en) * 1985-10-03 1988-11-08 Ortho Pharmaceutical Corporation Epoxides useful as antiallergic agents
US4808572A (en) * 1985-12-06 1989-02-28 Ciba-Geigy Corporation α-Hydroxy thioethers
KR870011086A (ko) * 1986-05-29 1987-12-19 벤자민 에프. 램버트 포스포리파제 a₂억제제 및 그의 합성방법
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
DE3724735A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten, sowie vorprodukte
DE3724669A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
AU610528B2 (en) * 1987-10-29 1991-05-23 Smithkline Beckman Corporation Leukotriene antagonists
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US5073571A (en) * 1988-06-16 1991-12-17 Washington University Method of inhibiting virus
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
US5149835A (en) * 1989-04-27 1992-09-22 University Of New Mexico Substituted mevalonolactones, and methods for stereoselective preparation thereof and desmethyl homologues thereof
EP0410244A1 (en) * 1989-07-27 1991-01-30 Bayer Ag Leukotriene antagonists
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
WO1991017149A1 (en) * 1990-05-01 1991-11-14 Smithkline Beecham Corporation 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20030212191A1 (en) * 2002-04-15 2003-11-13 Nippon Bee Chemical Co., Ltd. Aqueous primer coating composition, process for formation of coating film using said composition, and coated article
WO2003099272A1 (en) * 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1567142A4 (en) * 2002-11-20 2005-12-14 Errant Gene Therapeutics Llc TREATMENT OF PULMONARY CELLS WITH HISTONE DEACETYLASE INHIBITORS
JP5289707B2 (ja) * 2004-08-31 2013-09-11 住友ベークライト株式会社 オキシルアミノ基含有化合物
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7754838B2 (en) * 2006-08-08 2010-07-13 E.I. Du Pont De Nemours And Company Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3177227A (en) * 1963-01-30 1965-04-06 Shell Oil Co Lactone production
DE2945497A1 (de) * 1979-03-06 1980-10-09 Degussa Derivate der d-2-hydroxy-4-methylmercaptobuttersaeure, verfahren zu deren herstellung und deren verwendung
US4311645A (en) * 1980-03-24 1982-01-19 Hoffmann-La Roche Inc. Synthesis of SRS-active compounds
FR2479213A1 (fr) * 1980-03-28 1981-10-02 Roussel Uclaf Procede de preparation d'acide pentenoique possedant une fonction aldehyde
JPS57118555A (en) * 1981-01-13 1982-07-23 Ono Pharmaceut Co Ltd Leucotriene-analog compound, its preparation, and leucotriene-biosynthesis inhibiting agent containing said compound as active component
US4352757A (en) * 1981-02-02 1982-10-05 Smithkline Beckman Corporation Process for the preparation of esters of leukotriene A

Also Published As

Publication number Publication date
IL66056A0 (en) 1982-09-30
ES520670A0 (es) 1984-05-01
RO83706B (ro) 1984-03-30
KR840000483A (ko) 1984-02-22
DE3261237D1 (en) 1984-12-20
PH23051A (en) 1989-03-10
NZ200984A (en) 1985-01-31
ES8404307A1 (es) 1984-05-01
BG37226A3 (en) 1985-04-15
PL236992A1 (en) 1983-08-15
GB2101594B (en) 1985-12-24
PL240483A1 (en) 1983-09-12
FI822205A0 (fi) 1982-06-18
ES8307212A1 (es) 1983-07-01
IE53522B1 (en) 1988-12-07
US4513005A (en) 1985-04-23
PL137766B1 (en) 1986-07-31
ES8404322A1 (es) 1984-05-01
RO83706A (ro) 1984-03-15
FI77847B (fi) 1989-01-31
FI822205L (fi) 1982-12-19
DK271682A (da) 1982-12-19
ES513221A0 (es) 1983-07-01
GR76838B (sv) 1984-09-04
EP0068739B1 (en) 1984-11-14
KR890000622B1 (ko) 1989-03-22
CS241109B2 (en) 1986-03-13
PT75058A (en) 1982-07-01
AU549814B2 (en) 1986-02-13
PT75058B (en) 1985-07-26
PL240484A1 (en) 1983-09-12
PL240482A1 (en) 1983-09-12
GB2101594A (en) 1983-01-19
ES520671A0 (es) 1984-05-01
CA1224795A (en) 1987-07-28
CS456582A2 (en) 1985-07-16
AU8500882A (en) 1982-12-23
ZA824294B (en) 1983-06-29
EP0068739A1 (en) 1983-01-05
FI77847C (sv) 1989-05-10
IE821443L (en) 1982-12-18
HU192105B (en) 1987-05-28

Similar Documents

Publication Publication Date Title
DD202697A5 (de) Verfahren zur herstellung von alkansaeuren und deren derivate
DE2365035C2 (de) trans-Δ↑2↑-Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
CH636096A5 (de) Bicyclische prostaglandine, verfahren zu ihrer herstellung und pharmazeutische praeparate.
CH648286A5 (de) Prostaglandinderivate, ihre herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DE2440606A1 (de) Polyenverbindungen
EP0131221A2 (de) Thioether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0099538B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2032919A1 (de) Verfahren zur Herstellung von Polyen verbindungen
DE2440525A1 (de) Polyenverbindungen
DE3002677C2 (de) Prostaglandin-analoge, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
CH621780A5 (sv)
DE2330333A1 (de) 9-desoxy-prosta-5,9(10),13-triensaeurederivate
DE2610503C2 (de) Optisch aktive 13,14-Dehydro-11- desoxy-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Mittel
CH617186A5 (sv)
DE2337630A1 (de) Neue in 15-stellung substituierte prostansaeuren und ester davon, sowie verfahren zu ihrer herstellung
DE3613406A1 (de) 7-oxabicycloheptan-substituierte thioprostaglandin-analoge
DE3632893A1 (de) 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
EP0051247B1 (de) 4-Thia- und 4-Sulfinyl-PGI1-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Präparate
CH623570A5 (sv)
DE2825855C3 (de) 15-substituierte-ι-Pentanorprostaglandin-derivate
DE2825440C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE2618861A1 (de) 11-oxa-prostaglandinanaloga, ihre derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH635826A5 (de) Vitamin d(3)-derivate.
CH639950A5 (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten.
DE2221301A1 (de) Prostaglandin-Analoge und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee